Experience

Cooley Advises AvePoint on Its SG$260 Million Underwritten Public Offering and SGX Listing

September 22, 2025

Cooley advised AvePoint (Nasdaq: AVPT), a global leader in data security, governance and resilience, on its SG$260 million underwritten US Securities and Exchange Commission (SEC)-registered offering of common stock shares and concurrent listing on the Mainboard of the Singapore Exchange Securities Trading Limited (SGX-ST).

Read more

Related contacts

Tim Pitrelli
Partner, Singapore
John McKenna
Partner, Palo Alto
Steven Holm
Counsel, Singapore
Lukas Roth
Associate
Susan Choy
Associate, New York
Andrew Harline
Partner in Charge – Singapore, Singapore
Kevin King
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Mike Lincoln
Vice Chair, Reston
Aaron Pomeroy
Partner, Colorado
Francis Wheeler
Senior Counsel, Colorado
Andrew Epstein
Special Counsel, Seattle
Karen Tsai
Special Counsel, Washington, DC
Cecilia Bai
Associate , Singapore
Rick Jantz
Associate, Santa Monica
Hardy Zhou
Associate, New York
Alla Kagan
Paralegal Specialist, San Diego
Jason Minio
Paralegal Specialist, Boston

Related Practices & Industries

Vaxcyte Announces $862.5 Million Public Offering

February 5, 2024

Cooley advised Vaxcyte, a clinical-stage vaccine innovation company, on its $862.5 million follow-on public offering.

Read more

Related contacts

John McKenna
Partner, Palo Alto
Mark Weeks
Partner, Palo Alto
David D. Kim
Associate, San Francisco
Victoria Comesañas
Associate, Los Angeles
Megan Stallworth
Associate, Palo Alto
Charlie Kim
Partner, San Diego
Phil Mitchell
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Wyatt Kernell
Associate, Colorado
Mika Reiner Mayer
Partner, Palo Alto
Kimberly Bolin
Patent Agent, Palo Alto
Eileen Marshall
Partner, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Francis Wheeler
Senior Counsel, Colorado

Related Practices & Industries

Sagimet Biosciences – $112.5 Million Follow-On Offering

January 30, 2024

Cooley advised the underwriters in Sagimet Biosciences’ $112.5 million follow-on offering. Goldman Sachs, TD Cowen and Leerink Partners acted as joint book-running managers for the offering. JMP Securities is acting as lead manager for the offering. Sagimet Biosciences’ is a clinical-stage biopharmaceutical company developing novel fatty acid synthase inhibitors designed to target dysfunctional metabolic pathways in diseases resulting from the overproduction of the fatty acid palmitate. Partners John McKenna, Natalie Karam and Denny Won led the Cooley team.

Related contacts

John McKenna
Partner, Palo Alto
Denny Won
Partner, San Francisco
David D. Kim
Associate, San Francisco
Nicholas Yacoubian
Associate, Palo Alto
Victoria Comesañas
Associate, Los Angeles

Related Practices & Industries

Sagimet Biosciences Announces Upsized $85 Million IPO

July 18, 2023

Cooley advised the underwriters in the upsized initial public offering of Sagimet Biosciences, a clinical-stage biotechnology company, at $85 million.

Read more

Related contacts

John McKenna
Partner, Palo Alto
Denny Won
Partner, San Francisco
Natasha Leskovsek
Of Counsel, Washington, DC
David D. Kim
Associate, San Francisco
Victoria Comesañas
Associate, Los Angeles
Kate Walther
Paralegal Specialist, San Diego

Related Practices & Industries

Absolute Software Announces $870 Million Acquisition by Crosspoint Capital

May 15, 2023

Cooley advised Absolute Software, a data risk management solutions and endpoint security provider, on its acquisition by Crosspoint Capital for approximately $870 million, inclusive of debt.

Read more

Related contacts

Steve Tonsfeldt
Partner, Palo Alto
Rishab Kumar
Partner, Palo Alto
Milson Yu
Partner, Palo Alto
John McKenna
Partner, Palo Alto
Natalie D. Vernon
Associate, Colorado
Queenie Chen
Associate, Palo Alto
David Silverman
Partner, New York
Tracy Rubin
Partner, Palo Alto
Megan Browdie
Partner, Washington, DC
Patrick Flanagan
Partner, New York
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Ross Eberly
Partner, Santa Monica
Annie Froehlich
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Reuben Chen
Partner, Palo Alto

Related Practices & Industries

View more

Admissions and credentials

California

Memberships and affiliations

American Bar Association (ABA)

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.